Ledaborbactam etzadroxil is primarily used in the treatment of bacterial infections, particularly those caused by multidrug-resistant pathogens. It is often combined with other antibiotics to enhance their effectiveness against resistant strains. This compound is particularly valuable in treating complicated urinary tract infections (cUTIs) and intra-abdominal infections (IAIs) where traditional antibiotics may fail. Its application is crucial in hospital settings where resistant bacterial infections are more prevalent, helping to reduce the spread of these infections and improve patient outcomes.